Annual EBITDA
$65.03 M
+$82.08 M+481.15%
December 31, 2024
Summary
- As of February 20, 2025, INSP annual EBITDA is $65.03 million, with the most recent change of +$82.08 million (+481.15%) on December 31, 2024.
- During the last 3 years, INSP annual EBITDA has risen by +$103.65 million (+268.35%).
- INSP annual EBITDA is now at all-time high.
Performance
INSP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$56.75 M
+$40.59 M+251.03%
December 31, 2024
Summary
- As of February 20, 2025, INSP quarterly EBITDA is $56.75 million, with the most recent change of +$40.59 million (+251.03%) on December 31, 2024.
- Over the past year, INSP quarterly EBITDA has stayed the same.
- INSP quarterly EBITDA is now at all-time high.
Performance
INSP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$65.03 M
+$26.27 M+67.81%
December 31, 2024
Summary
- As of February 20, 2025, INSP TTM EBITDA is $65.03 million, with the most recent change of +$26.27 million (+67.81%) on December 31, 2024.
- Over the past year, INSP TTM EBITDA has stayed the same.
- INSP TTM EBITDA is now at all-time high.
Performance
INSP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
INSP EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +481.1% | 0.0% | 0.0% |
3 y3 years | +268.4% | +3911.6% | +268.4% |
5 y5 years | +312.6% | +779.1% | +312.6% |
INSP EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +259.6% | at high | +400.2% | at high | +240.0% |
5 y | 5-year | at high | +220.1% | at high | +353.6% | at high | +216.5% |
alltime | all time | at high | +220.1% | at high | +353.6% | at high | +216.5% |
Inspire Medical Systems EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $65.03 M(-481.2%) | $56.75 M(+251.0%) | $65.03 M(+67.8%) |
Sep 2024 | - | $16.17 M(+149.4%) | $38.75 M(+291.9%) |
Jun 2024 | - | $6.48 M(-145.1%) | $9.89 M(-178.9%) |
Mar 2024 | - | -$14.38 M(-147.2%) | -$12.53 M(-26.5%) |
Dec 2023 | -$17.06 M(-58.1%) | $30.48 M(-340.1%) | -$17.06 M(-61.0%) |
Sep 2023 | - | -$12.69 M(-20.4%) | -$43.70 M(-5.9%) |
Jun 2023 | - | -$15.94 M(-15.7%) | -$46.43 M(+5.7%) |
Mar 2023 | - | -$18.91 M(-591.8%) | -$43.93 M(+7.8%) |
Dec 2022 | -$40.73 M(+5.5%) | $3.84 M(-124.9%) | -$40.73 M(-11.6%) |
Sep 2022 | - | -$15.43 M(+14.8%) | -$46.07 M(+14.9%) |
Jun 2022 | - | -$13.44 M(-14.5%) | -$40.10 M(+3.1%) |
Mar 2022 | - | -$15.71 M(+954.9%) | -$38.90 M(+0.7%) |
Dec 2021 | -$38.62 M(-28.6%) | -$1.49 M(-84.3%) | -$38.62 M(-11.8%) |
Sep 2021 | - | -$9.47 M(-22.5%) | -$43.80 M(-0.2%) |
Jun 2021 | - | -$12.23 M(-20.8%) | -$43.89 M(-18.8%) |
Mar 2021 | - | -$15.44 M(+131.4%) | -$54.03 M(-0.2%) |
Dec 2020 | -$54.13 M | -$6.67 M(-30.2%) | -$54.13 M(-3.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | -$9.55 M(-57.3%) | -$55.82 M(+3.7%) |
Jun 2020 | - | -$22.38 M(+44.0%) | -$53.85 M(+39.9%) |
Mar 2020 | - | -$15.53 M(+85.9%) | -$38.50 M(+25.8%) |
Dec 2019 | -$30.59 M(+68.7%) | -$8.36 M(+10.2%) | -$30.59 M(+16.7%) |
Sep 2019 | - | -$7.58 M(+8.0%) | -$26.22 M(+16.3%) |
Jun 2019 | - | -$7.02 M(-7.9%) | -$22.54 M(+8.7%) |
Mar 2019 | - | -$7.63 M(+91.4%) | -$20.73 M(+14.3%) |
Dec 2018 | -$18.13 M(+17.2%) | -$3.98 M(+1.8%) | -$18.13 M(+2.1%) |
Sep 2018 | - | -$3.91 M(-24.9%) | -$17.76 M(+2.3%) |
Jun 2018 | - | -$5.21 M(+3.6%) | -$17.36 M(+5.7%) |
Mar 2018 | - | -$5.03 M(+39.2%) | -$16.43 M(+6.2%) |
Dec 2017 | -$15.47 M(-9.6%) | -$3.61 M(+2.6%) | -$15.47 M(+30.4%) |
Sep 2017 | - | -$3.52 M(-17.7%) | -$11.86 M(+42.2%) |
Jun 2017 | - | -$4.28 M(+5.3%) | -$8.34 M(+105.3%) |
Mar 2017 | - | -$4.06 M | -$4.06 M |
Dec 2016 | -$17.12 M(-12.9%) | - | - |
Dec 2015 | -$19.65 M | - | - |
FAQ
- What is Inspire Medical Systems annual EBITDA?
- What is the all time high annual EBITDA for Inspire Medical Systems?
- What is Inspire Medical Systems annual EBITDA year-on-year change?
- What is Inspire Medical Systems quarterly EBITDA?
- What is the all time high quarterly EBITDA for Inspire Medical Systems?
- What is Inspire Medical Systems quarterly EBITDA year-on-year change?
- What is Inspire Medical Systems TTM EBITDA?
- What is the all time high TTM EBITDA for Inspire Medical Systems?
- What is Inspire Medical Systems TTM EBITDA year-on-year change?
What is Inspire Medical Systems annual EBITDA?
The current annual EBITDA of INSP is $65.03 M
What is the all time high annual EBITDA for Inspire Medical Systems?
Inspire Medical Systems all-time high annual EBITDA is $65.03 M
What is Inspire Medical Systems annual EBITDA year-on-year change?
Over the past year, INSP annual EBITDA has changed by +$82.08 M (+481.15%)
What is Inspire Medical Systems quarterly EBITDA?
The current quarterly EBITDA of INSP is $56.75 M
What is the all time high quarterly EBITDA for Inspire Medical Systems?
Inspire Medical Systems all-time high quarterly EBITDA is $56.75 M
What is Inspire Medical Systems quarterly EBITDA year-on-year change?
Over the past year, INSP quarterly EBITDA has changed by $0.00 (0.00%)
What is Inspire Medical Systems TTM EBITDA?
The current TTM EBITDA of INSP is $65.03 M
What is the all time high TTM EBITDA for Inspire Medical Systems?
Inspire Medical Systems all-time high TTM EBITDA is $65.03 M
What is Inspire Medical Systems TTM EBITDA year-on-year change?
Over the past year, INSP TTM EBITDA has changed by $0.00 (0.00%)